REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 181 filers reported holding REGENXBIO INC in Q3 2021. The put-call ratio across all filers is 4.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $492,450 | -19.8% | 29,918 | -2.6% | 0.00% | – |
| Q2 2023 | $614,133 | -9.6% | 30,722 | -14.5% | 0.00% | – |
| Q1 2023 | $679,549 | -9.6% | 35,936 | +8.4% | 0.00% | – |
| Q4 2022 | $751,865 | +142.5% | 33,151 | +182.3% | 0.00% | – |
| Q3 2022 | $310,000 | -67.7% | 11,745 | -59.4% | 0.00% | – |
| Q1 2022 | $959,000 | -33.9% | 28,900 | -34.9% | 0.00% | – |
| Q4 2021 | $1,451,000 | -87.6% | 44,394 | -84.1% | 0.00% | -100.0% |
| Q3 2021 | $11,731,000 | +512.9% | 279,849 | +468.1% | 0.00% | – |
| Q2 2021 | $1,914,000 | +192.2% | 49,259 | +156.5% | 0.00% | – |
| Q1 2021 | $655,000 | -84.4% | 19,203 | -79.3% | 0.00% | -100.0% |
| Q4 2020 | $4,210,000 | +197.1% | 92,795 | +80.3% | 0.00% | +100.0% |
| Q3 2020 | $1,417,000 | +492.9% | 51,479 | +692.0% | 0.00% | – |
| Q2 2020 | $239,000 | +6.2% | 6,500 | +2.8% | 0.00% | – |
| Q3 2019 | $225,000 | -73.1% | 6,320 | -43.0% | 0.00% | -100.0% |
| Q3 2018 | $837,000 | +75.8% | 11,081 | -23.3% | 0.00% | 0.0% |
| Q3 2017 | $476,000 | – | 14,445 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |